Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials
Bionexus Gene Lab Corp. Total Liabilities 2018–2025
Bionexus Gene Lab Corp. annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Bionexus Gene Lab Corp. total liabilities for the quarter ending December 31, 2025 were 637,856, a 69.78% decrease year-over-year.
- Bionexus Gene Lab Corp. total liabilities for 2025 were 637,856, a 69.78% decrease from 2024.
- Bionexus Gene Lab Corp. total liabilities for 2024 were 2.1M, a 21.19% increase from 2023.
- Bionexus Gene Lab Corp. total liabilities for 2023 were 1.7M, a 16.06% decrease from 2022.
- Bionexus Gene Lab Corp. total liabilities for 2022 were 2.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bionexus Gene Lab Corp. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1 |
| 2024 | $2 |
| 2023 | $2 |
| 2022 | $2 |
| 2021 | $2 |
| 2020 | $3 |
| 2019 | $0 |
| 2018 | $0 |
| Bionexus Gene Lab Corp. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $1 |
| 2024-12-31 | $2 |
| 2023-12-31 | $2 |
| 2022-12-31 | $2 |
| 2021-12-31 | $2 |
| 2020-12-31 | $3 |
| 2019-12-31 | $0 |
| 2018-12-31 | $0 |
Bionexus Gene Lab Corp. Total Liabilities — FAQ
Bionexus Gene Lab Corp. (BGLC) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGLC's total liabilities history?
The chart and table above show Bionexus Gene Lab Corp.'s total liabilities by year and by quarter, including the growth rate.